FDA Green-Lights Robotic System for Dental Implants
The Federal Drug Administration (FDA) recently approved a new technology that will provide guidance for surgeons—both prior to and during an operation—performing dental implant procedures.

The robotic navigation system, nicknamed Yomi, “can reduce surgery time and improve accuracy compared to procedures performed free-hand,” according to Alon Mozes, Chief Executive Officer of the company that designed the system, Neocis.

Mozes has been involved in the development of several robotic surgery startups, including a pioneer in robotic-arm assisted orthopedic surgery, MAKO Surgical, which was acquired by Stryker in 2013. His most recent project, however, comes from his own original idea to target a previously neglected need in the growing dental implant market.

Mozes co-founded Neocis alongside Juan Salcedo. The company’s initial round of investors included Fred Moll, co-founder of Intuitive Surgical, the company that pioneered the da Vinci robotic system.

Many in the dental industry consider Neocis’ technology to be a ‘game-changer’ and Mozes described FDA approval as an “important milestone” for his startup. He went on to note that their most important next step is to introduce the benefits of the system to dentists nationwide.

According to Jeffrey Ganeles, a periodontist at the South Florida Center for Periodontics and Implant Dentistry, “Yomi is a precision instrument that makes sure your implant goes exactly where you planned to put it. I’ve done thousands of implants free-hand. Yomi will be a game changer for dental implant surgery.”

The American Academy of Implant Dentistry estimates that nearly three million patients receive dental implant surgery in the U.S. every year. They also predict that this number will expand rapidly in the coming years.

Furthermore, the global market for dental implants is predicted to top $7.8 billion by 2020. The expansion of this market is being driven by a number of factors, including aging population sand increased awareness of the importance of dental health.

Traditionally, there is a distrust of robotic components when it comes to performing certain surgical functions. However, recent advances in technology have resulted in a more widespread acceptance of robotic surgical systems.

With the number of robotic procedures in the U.S. topping 500,000 since 2015, a number of major players in the medical technology industry have made recent investments in the market. This includes household names like Johnson & Johnson, Verily, and Medtronic.

According to Xi Chen, analyst for Decision Resources Group, robotic surgery is expected to “stay, grow, and evolve.” With that said, the medical device industry will continue to play a large role in proving the long-term value of robotic surgery. Improving device training, making robotic systems more cost effective, and the large-scale collection of outcomes data are just a few ways in which the industry can work to provide concrete evidence that investments in robotic surgery systems are worthwhile.

###


Be sure to check out OnCorp Direct's service offering
Share |
Posted by: DSR
Monday, April 3, 2017
Tag: Dental
Archive
Business Start Ups
Healthcare
Dental
Legal
Subscribe to the OnCorp Direct RSS feed and stay up to date with what's going on within the blog.
Address: 1033 Bay Street, Suite 313
Toronto, Ontario M5S 3A5 Canada
Email: info@oncorp.com
Phone: (416) 964-CORP (2677)
Toll Free: 1-800-461-7772
Fax: (416) 964-3975
Website: www.oncorp.com
Facebook: www.facebook.com/OnCorpDirect
Twitter: http://twitter.com/OnCorpDirect
RSS: http://blog.oncorp.com/oncorp-full.xml
To Comment on this blog, email: comments@serptastic.com
OnCorp Direct Blog est. 2010 | Site Maintained By: SERPtastic.com